The only exception appears to be hepatocellular carcinoma cells, which express lower levels of ATF5 than normal liver cells; this discrepancy may be due to epigenetic silencing of ATF5 in hepatocellular carcinoma cells through promoter methylation [12]. The gene discussed is ATF5; the disease is hepatocellular carcinoma.